Besponsa
Besponsa Products are primarily used for
Acute lymphoblastic leukemia
About Besponsa Products
Uses of Besponsa Products
Inotuzumab Ozogamacin is used in the treatment of Acute lymphoblastic leukemia.
Besponsa Products side effects
Common
Side Effects of Besponsa are Low blood platelets, Decreased white blood cell count (neutrophils), Infection, Anemia (low number of red blood cells), Decreased white blood cell count (lymphocytes), Fatigue, Hemorrhage, Fever, Nausea, Headache, Febrile neutropenia, Increased transaminase level in blood, Abdominal pain, Increased gamma-glutamyltransferase, Increased bilirubin in the blood.
How Besponsa Products work
Inotuzumab Ozogamacin contains Inotuzumab Ozogamicin, an antineoplastic agent that treats relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL) in adults. targets CD22 antigen expressed on immature B-cell lymphocytes and blocks further growth of tumor cells. This medicine restores normal blood counts and helps achieve complete remission from the disease.
Products for Besponsa
Besponsa 1mg Injection
vial of 1 Injection
MRP
₹330000